NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic pro...
Neumora Therapeutics Inc [NMRA] stock is trading at $0.9, up 8.97%. Until recently, the best way to ...
Key Insights Institutions' substantial holdings in Neumora Therapeutics implies that they have signi...
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have received an average recomm...
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) has been given a consensus recommendation...